HGSI

HGSI: To Present At Piper Jaffray Health Care Conference @ 13:30 ET [delayed] - 12/02 - 11:53 AM ET

BRIEF-Human Genome Sciences files mixed shelf - 11/28 - 09:24 AM ET

Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Piper Jaffray Conference - 11/26 - 08:00 AM ET

HGSI: To Present At Lazard Capital Healthcare Conference @ 11:00 ET [delayed] - 11/19 - 09:24 AM ET

BRIEF-Human Genome Sciences reports Q3 results - 11/06 - 04:22 PM ET

Human Genome Sciences Announces Third Quarter 2008 Financial Results and Key Developments - 11/06 - 04:05 PM ET

HGSI: Q3 Earnings Call @ 17:00 ET Today [delayed] - 11/06 - 02:26 PM ET

Human Genome Sciences to Sponsor Conference Call to Discuss Third Quarter 2008 Financial Results - 10/30 - 08:00 AM ET

BRIEF: Phase Bioscience appoints Craig Rosen executive chairman - 10/09 - 04:49 AM ET

HGSI: To Present At JMP Securities Healthcare Conference @ 10:30 ET [delayed] - 10/06 - 08:53 AM ET

Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at JMP Securities Conference - 10/03 - 08:00 AM ET

HGSI: To Present At UBS Global Life Sciences Conference @ 11:30 ET [delayed] - 09/22 - 09:53 AM ET

HGSI: Conference call regarding Invites Investors to Listen to Webcast of Presentation at UBS Conference @ 11:30 ET Today [delayed] - 09/22 - 08:50 AM ET

Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at UBS Conference - 09/18 - 08:00 AM ET

Nextrials Executives to Discuss Quality Outsourcing and Data Collection at 2008 SCDM Fall Conference - 09/15 - 08:00 AM ET

HGSI: To Present At Baird Small Cap Health Care Conference @ 10:15 ET [delayed] - 09/10 - 08:54 AM ET

Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Robert W. Baird Conference - 09/08 - 08:00 AM ET

HGSI: To Present At Thomas Weisel Healthcare Conference @ 08:35 ET [delayed] - 09/04 - 08:25 AM ET

Human Genome Sciences Announces Process Development and Manufacturing Alliance With Hospira - 09/04 - 07:00 AM ET

Human Genome Sciences Reports Initial Results of Randomized Phase 2 Trial of HGS-ETR1 in Combination With Bortezomib in Advanced Multiple Myeloma - 09/02 - 04:05 PM ET

Page 1 of 7     1  2   3   4   5   >   >>|     Previous  |  Next

<< Back to Stock Index